Biotech · Private company
Chong Kun Dang Pharmaceutical
Track this companyFree. Adds Chong Kun Dang Pharmaceutical to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CKD-703Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CKD-508 TabletPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- CKD-508 TabletPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CKD-510 capsule (reference)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CKD-510 tablet (test)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- RosuvastatinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung CancerPHASE1_PHASE2 · RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT07439094 · fetched Nov 12, 2026
- A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male ParticipantsPHASE1 · COMPLETED · started May 14, 2025ClinicalTrials.gov NCT06979973 · fetched Nov 12, 2026
- A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy ParticipantsPHASE1 · COMPLETED · started Nov 14, 2024ClinicalTrials.gov NCT06727396 · fetched Nov 12, 2026
- A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy SubjectsPHASE1 · COMPLETED · started Aug 24, 2022ClinicalTrials.gov NCT05526742 · fetched Nov 12, 2026